Light Source Matching Strategies for Optimal Treatment Efficacy of HMME and m ‐THPC in Photodynamic Therapy of Vascular Lesions
Lasers in Surgery and Medicine · 2026-09 · 58 (7) · 550-563
DOI: 10.1002/lsm.70150 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Lasers in Surgery and Medicine, online erschienen am 18.05.2026. Verfasst von Zhewen Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head Neck Oncology, Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, College of Sto…. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Hematoporphyrins, Mesoporphyrins. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Clinical Medical Research Center Project of Hainan Provincial Department of Science and Technology, Projects of the National Clinical Research Center for Oral Diseases, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study aims to compare the therapeutic effects of hematoporphyrin monomethyl ether (HMME) and meta ‐tetrahydroxyphenylchlorin ( m ‐THPC) under single‐wavelength and dual‐wavelength light irradiation in photodynamic therapy (PDT), and aims to optimize light source matching strategies to enhance targeted treatment of vascular lesions.
Methods
This study employed the ABDA probe assay to evaluate the in vitro reactive oxygen species (ROS) generation efficiency of two photosensitizers (HMME and m ‐THPC) under 410, 532, 653 nm, and dual‐wavelength (410 + 653 nm) irradiation. Using Leghorn chicken comb as a vascular malformation model, we further assessed in vivo vascular damage effects, thermal responses, tissue‐level ROS production, and apoptosis rates.
Results
This study demonstrated that HMME exhibited optimal photodynamic efficacy at 410 nm, while m ‐THPC maintained substantial photodynamic efficacy at both 410 and 653 nm, with the dual‐wavelength combination (410 + 653 nm) showing complementary activation for m ‐THPC but reduced efficacy for HMME. The 532 nm wavelength, though effective for vascular damage, caused significant thermal injury and non‐specific apoptosis of non‐target cells, highlighting its clinical limitations. Histopathological analysis confirmed that 410 and 653 nm irradiation selectively targeted vasculature with minimal epidermal damage, whereas 532 nm led to widespread tissue necrosis. ROS generation and apoptotic assays revealed that HMME's cytotoxicity was strongest at 410 nm, while m ‐THPC performed well across multiple wavelengths, and particularly benefited from dual‐wavelength activation.
Conclusion
Photosensitizer activation efficiency is highly wavelength‐dependent, with HMME performing best at shorter wavelengths (410 nm) while m ‐THPC maintains considerable efficacy at longer wavelengths (653 nm). The dual‐wavelength combination (410 + 653 nm) can partially overcome limitations of single wavelengths, providing references for clinical light source optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head Neck Oncology, Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai,…
- National Clinical Research Center for Oral Diseases, Shanghai, China.
- Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, China.
- Department of General Dentistry, Pudong New District Ophthalmology and Odontology Dispensary, Shanghai, China.
- Department of Health, 940 Hospital of PLA Joint Logistic Support, Lanzhou, China.
ORCID-Profile: Ting Zhu
Förderung
- Clinical Medical Research Center Project of Hainan Provincial Department of Science and Technology
- Projects of the National Clinical Research Center for Oral Diseases
- National Natural Science Foundation of China
- Shanghai Sailing Program
- Interdisciplinary Program of Shanghai Jiao Tong University
Zitieren
APA
Song, Z., Fu, S., Liu, Y., Zhou, G., & Zhu, T. (2026). Light Source Matching Strategies for Optimal Treatment Efficacy of HMME and m ‐THPC in Photodynamic Therapy of Vascular Lesions. Lasers in Surgery and Medicine, 58(7), 550-563. https://doi.org/10.1002/lsm.70150
Vancouver
Song Z, Fu S, Liu Y, Zhou G, Zhu T. Light Source Matching Strategies for Optimal Treatment Efficacy of HMME and m ‐THPC in Photodynamic Therapy of Vascular Lesions. Lasers in Surgery and Medicine. 2026;58(7):550-563. doi:10.1002/lsm.70150
BibTeX
@article{Song2026,
author = {Song, Zhewen and Fu, Shuiting and Liu, Yan and Zhou, Guoyu and Zhu, Ting},
title = {Light Source Matching Strategies for Optimal Treatment Efficacy of HMME and m ‐THPC in Photodynamic Therapy of Vascular Lesions},
journal = {Lasers in Surgery and Medicine},
year = {2026},
volume = {58},
number = {7},
pages = {550--563},
doi = {10.1002/lsm.70150}
}
EUVIMED